CD4 and AIDS: A total of 66 individuals had at least one component of primary study outcome: 27 individuals reached a CD4 T lymphocyte count below 350 cells/μL, 57 individuals started ART, and no individual reached an AIDS-defining event as a primary outcome, and no one died during the study period.